ID
39428
Beskrivning
Study ID: 111569 Clinical Study ID: 111569 Study Title: A fixed dose, dose-response study for ropinirole prolonged release (PR) as adjunctive treatment to L-Dopa in patients with advanced Parkinson's disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01494532 Sponsor: GlaxoSmithKline Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Ropinirole, placebo Study Indication: Parkinson's Disease
Nyckelord
Versioner (7)
- 2019-12-11 2019-12-11 -
- 2019-12-11 2019-12-11 -
- 2019-12-11 2019-12-11 -
- 2019-12-11 2019-12-11 -
- 2019-12-16 2019-12-16 -
- 2020-01-09 2020-01-09 -
- 2020-01-09 2020-01-09 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
9 januari 2020
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Ropinirole prolonged release (PR) as adjunctive treatment to L-Dopa in patients with advanced Parkinson's disease (NCT01494532)
Visit 4; Visit 6: Visit 8; Maintenance 2; Early Withdrawal; Follow up; Unscheduled - Pregnancy
Beskrivning
Pregnancy
Alias
- UMLS CUI-1
- C0032961
Beskrivning
Did a female partner of a male subject become pregnant during the study?
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0919624
Beskrivning
Did the subject become pregnant during the study?
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0032961
Inga kommentarer